Harmony Biosciences Holdings, INC. 8-K Filing

Ticker: HRMY · Form: 8-K · Filed: Oct 1, 2024 · CIK: 1802665

Harmony Biosciences Holdings, INC. 8-K Filing Summary
FieldDetail
CompanyHarmony Biosciences Holdings, INC. (HRMY)
Form Type8-K
Filed DateOct 1, 2024
Pages2
Reading Time2 min
Key Dollar Amounts$0.00001
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 8-K filing submitted by Harmony Biosciences Holdings, INC. (ticker: HRMY) to the SEC on Oct 1, 2024.

What are the key financial figures in this filing?

Key dollar amounts include: $0.00001 () on which registered Common Stock, $0.00001 par value per share HRMY The Nasdaq).

How long is this filing?

Harmony Biosciences Holdings, INC.'s 8-K filing is 2 pages with approximately 579 words. Estimated reading time is 2 minutes.

Where can I view the full 8-K filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 579 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-10-01 08:45:45

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Harmony Biosciences Holdings, Inc. (the "Company") will host its first Investor Day on October 1, 2024, in New York City, using the presentation attached to this Current Report on Form 8-K as Exhibit 99.1 (the "Investor Presentation"). In connection with the Investor Presentation, the Company issued a press release, which is attached to this Current Report on Form 8-K as Exhibit 99.2.The Investor Presentation will be made available upon the conclusion of the event on the investors page of the Company's website at https://ir.harmonybiosciences.com/news-events/presentations. The information in this report, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

01(d). Financial Statements and Exhibits

Item 9.01(d). Financial Statements and Exhibits. The following exhibits are furnished as part of this report on Form 8-K: Exhibit No. Description 99.1 Harmony Biosciences Holdings, Inc. Investor Day Presentation, October 1, 2024. 99.2 Press release issued by the Company, dated October 1, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HARMONY BIOSCIENCES HOLDINGS, INC. Date: October 1, 2024 By: /s/ Sandip Kapadia Sandip Kapadia Chief Financial Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing